Exane Derivatives’s Aimco AIV Stock Holding History

Exane Derivatives’s Portfolio AIV Stock Details AIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-90	Closed	-$405	–	827
2020 Q3	$405	Hold	90	–	–	﹤0.01%	692
2020 Q2	$452	Hold	90	–	–	﹤0.01%	621
2020 Q1	$422	Hold	90	–	–	﹤0.01%	616
2019 Q4	$625	Hold	90	–	–	﹤0.01%	591
2019 Q3	$626	Hold	90	–	–	﹤0.01%	570
2019 Q2	$601	Sell	90 -1,667	-95%	-$11.1K	﹤0.01%	588
2019 Q1	$11.8K	Sell	1,757 -31,018	-95%	-$200K	﹤0.01%	384
2018 Q4	$192K	Buy	32,775 +32,632	+22,820%	+$194K	0.03%	251
2018 Q3	$827	Hold	143	–	–	﹤0.01%	555
2018 Q2	$805	Sell	143 -55,182	-100%	-$300K	﹤0.01%	544
2018 Q1	$299K	Buy	55,325 +55,317	+691,463%	+$296K	0.06%	198
2017 Q4	$44	Sell	8 -111,123	-100%	-$654K	﹤0.01%	571
2017 Q3	$649K	Sell	111,131 -2,672	-2%	-$15.9K	0.12%	117
2017 Q2	$651K	Buy	+113,803	New	+$664K	0.14%	118
2016 Q4	–	Sell	-128,922	Closed	-$788K	–	647
2016 Q3	$788K	Buy	128,922 +59,371	+85%	+$357K	0.12%	108
2016 Q2	$409K	Buy	+69,551	New	+$385K	0.07%	148

Other funds holding AIV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Exane Derivatives's AIV Position: Q4 2020 in Review

Exane Derivatives sold out of Aimco (AIV) in Q4 2020, closing a stake of 90 shares — an estimated $405 sold.

Exane Derivatives first reported a position in AIV in Q2 2016 and held it in 16 quarters. The position peaked at $788K in Q3 2016. 263 funds tracked by Wall St. Rank hold AIV as of Q4 2020.

Exane Derivatives reported no remaining Aimco position as of Q4 2020 after selling out during the quarter.
Exane Derivatives sold 90 Aimco shares in Q4 2020, an estimated $405.
Exane Derivatives first reported a position in Aimco in Q2 2016 and held it in 16 quarters.
Exane Derivatives's Aimco position peaked at $788K in Q3 2016.
263 funds tracked by Wall St. Rank held Aimco as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.